Additional Volume PF-07321332 Supply Agreement for Pandemic Purposes
Department of Health and Social Care · Awarded
- Buyer
- Department of Health and Social Care
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-030bf6
- Published
- 2022-01-17
Tender summary
Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. This agreement is for the procurement of 2,500,000 units of PF-07321332/ritonavir. It is one of the first oral and direct-acting antiviral drugs globally and is part of the UK’s multi-layered approach to COVID-19.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access